Barclay Phillips
Director/Board Member at IMMUNIC, INC.
Net worth: - $ as of 2024-04-29
Profile
Mr. Barclay A.
Phillips is a Chief Operating & Financial Officer at Ribometrix, Inc. and a Lead Independent Director at Immunic, Inc. He is on the Board of Directors at Immunic, Inc. and Immunic AG.
Mr. Phillips was previously employed as a CFO & Senior VP-Corporate Development by G1 Therapeutics, Inc., a Chief Financial Officer, Treasurer & Senior VP by Novavax, Inc., a Chief Financial Officer & Senior Vice President by Micromet, Inc., a Managing Director by Vector Asset Management, Inc., a Managing Director by Vector Fund Management LP, a Director-Private Placements by INVESCO Funds Group, Inc., a General Partner by Apjohn Ventures LLC, a Director-Private Placements by INVESCO Institutional (N.A.), Inc., a Principal by PaineWebber, Inc., and a Principal by Shearson Lehman Hutton, Inc. He also served on the board at Acorda Therapeutics, Inc. and CancerVax Corp.
He received his undergraduate degree from the University of Colorado Boulder.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMMUNIC, INC.
-.--% | 2024-03-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Barclay Phillips active positions
Companies | Position | Start |
---|---|---|
IMMUNIC, INC. | Director/Board Member | 2019-11-18 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Director/Board Member | - |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Director of Finance/CFO | 2020-08-03 |
Former positions of Barclay Phillips
Companies | Position | End |
---|---|---|
G1 THERAPEUTICS, INC. | Director of Finance/CFO | 2019-05-09 |
NOVAVAX, INC. | Director of Finance/CFO | 2017-11-09 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Director of Finance/CFO | 2009-07-28 |
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Chief Investment Officer | 2008-09-29 |
Vector Fund Management LP
Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Corporate Officer/Principal | 2008-07-31 |
Training of Barclay Phillips
University of Colorado Boulder | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
NOVAVAX, INC. | Health Technology |
ACORDA THERAPEUTICS, INC. | Health Technology |
G1 THERAPEUTICS, INC. | Health Technology |
IMMUNIC, INC. | Health Technology |
Private companies | 11 |
---|---|
Invesco Advisers, Inc.
Invesco Advisers, Inc. Investment ManagersFinance Invesco Advisers, Inc. is a SEC-registered investment advisor headquartered in Atlanta, Georgia. They are a subsidiary of Invesco Group Services, Inc., ultimately held by Invesco Ltd. (NYSE: IVZ). The firm was founded in 1986 and previously known as Invesco Institutional NA, Inc. until April 2010 when Invesco Ltd. consolidated the businesses of their US investment advisors (Invesco AIM Advisors, Inc., Invesco AIM Capital Management, Inc., Invesco AIM Private Asset Management, Inc. and Invesco Global Asset Management NA, Inc.) under the name Invesco Advisers, Inc. They provide discretionary and non-discretionary investment advisory services to individuals, institutional and high net-worth clients through separate accounts, wrap fee programs and US registered investment companies and other Commingled Funds. | Finance |
INVESCO Funds Group, Inc.
INVESCO Funds Group, Inc. Investment ManagersFinance Part of Invesco Ltd., INVESCO Funds Group, Inc. is a company based in Denver, CO. | Finance |
CancerVax Corp. | Commercial Services |
Vector Fund Management LP
Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Finance |
PaineWebber, Inc. | Finance |
Apjohn Ventures LLC
Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Finance |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Shearson Lehman Hutton, Inc. | Finance |
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Finance |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
- Stock Market
- Insiders
- Barclay Phillips